$15.07 million raised so far by Nico via private placement

XDATA – February 19th 2016
Nico disclosed selling 84% of its $18 million non-brokered equity offering to forty-one investors. The sale started on February 5th according to the document filed at the SEC. Based on the offering’s structure, the company has until February 2017 to raise an extra $2.93 million. The company closed three previous unregistered private placements which raised an estimated $21.68 million.
Nico develops technology for the field of corridor surgery, including Cranial, ENT, Spinal and Otolaryngology where access to the surgical site is limited. The company’s technology and products are designed to progress corridor surgery by creating instruments that allow for access through smaller openings and resection of soft tissue abnormalities. Investors include Rose-Hulman Institute of Technology, River Cities Capital Fund, CHV Capital, Cornelius Private Investments, and Twilight Venture Partners.
The company is headquartered in Indianapolis IN. Nico elected to keep its revenues undisclosed.
The executive team includes Jeffrey L Hanthorn, Jim Pearson and Joseph L Mark.
The board of directors includes J Carter McNabb, James R Baumgardt, Keith E Brauer and Niles L Noblitt.

The company has raised an estimated total of $36.76 million via private unregistered security offerings.

Offering recap
Status: First close
Company: Nico
Industry: Other Health Care
Amount offered: $18 million
Amount placed: $15.07 million
SEC filing: Source
First sale: 02-05-2016
Data as of: 02-19-2016

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s